CJC-1295 w/o DAC 5MG / Ipamorelin 5MG
CJC-1295 w/o DAC / Ipamorelin is a research blend pairing a GHRH analog with a selective GHRP. Preclinical studies investigate their synergistic stimulation of the growth hormone axis in laboratory models.
Key Research Areas
- • CJC-1295 studied for GHRH-mediated GH and IGF-1 elevation in research models.
- • Ipamorelin investigated for selective ghrelin receptor agonism and pulsatile GH release.
- • Blend examined for complementary pathways enhancing GH secretion profiles in laboratory settings.
Product Specifications
| Product |
CJC-1295 w/o DAC / Ipamorelin Blend |
| CAS Number |
CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4 |
| Molecular Formula |
CJC-1295: C152H252N44O42; Ipamorelin: C38H49N9O5 |
| Molar Mass |
CJC-1295: ~3367.9 g/mol; Ipamorelin: 711.85 g/mol |
| Sequence |
CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Synonyms |
CJC-1295 no DAC / Ipamorelin Blend |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.